Trojan Bio develops a novel immunotherapy modality that harnesses antiviral immunity to combat cancer. 

Trojan antibodies (Abs) operate as classical therapeutic Abs and possess the unique ability to label cancer cells as if they were virus-infected, resulting in a robust and powerful immune response.